Human Induced Pluripotent Stem Cell-Derived Vascular Cells: Recent Progress and Future Directions
Human induced pluripotent stem cells (hiPSCs) hold great promise for cardiovascular regeneration following ischemic injury. Considerable effort has been made toward the development and optimization of methods to differentiate hiPSCs into vascular cells, such as endothelial and smooth muscle cells (E...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/09ffb386a6834076a432c3504635c24b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:09ffb386a6834076a432c3504635c24b |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:09ffb386a6834076a432c3504635c24b2021-11-25T18:00:21ZHuman Induced Pluripotent Stem Cell-Derived Vascular Cells: Recent Progress and Future Directions10.3390/jcdd81101482308-3425https://doaj.org/article/09ffb386a6834076a432c3504635c24b2021-11-01T00:00:00Zhttps://www.mdpi.com/2308-3425/8/11/148https://doaj.org/toc/2308-3425Human induced pluripotent stem cells (hiPSCs) hold great promise for cardiovascular regeneration following ischemic injury. Considerable effort has been made toward the development and optimization of methods to differentiate hiPSCs into vascular cells, such as endothelial and smooth muscle cells (ECs and SMCs). In particular, hiPSC-derived ECs have shown robust potential for promoting neovascularization in animal models of cardiovascular diseases, potentially achieving significant and sustained therapeutic benefits. However, the use of hiPSC-derived SMCs that possess high therapeutic relevance is a relatively new area of investigation, still in the earlier investigational stages. In this review, we first discuss different methodologies to derive vascular cells from hiPSCs with a particular emphasis on the role of key developmental signals. Furthermore, we propose a standardized framework for assessing and defining the EC and SMC identity that might be suitable for inducing tissue repair and regeneration. We then highlight the regenerative effects of hiPSC-derived vascular cells on animal models of myocardial infarction and hindlimb ischemia. Finally, we address several obstacles that need to be overcome to fully implement the use of hiPSC-derived vascular cells for clinical application.Jee Eun OhCholomi JungYoung-sup YoonMDPI AGarticlehuman induced pluripotent stem cellendothelial cellsmooth muscle cellstem cellcardiovascular diseaseregenerative medicineDiseases of the circulatory (Cardiovascular) systemRC666-701ENJournal of Cardiovascular Development and Disease, Vol 8, Iss 148, p 148 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
human induced pluripotent stem cell endothelial cell smooth muscle cell stem cell cardiovascular disease regenerative medicine Diseases of the circulatory (Cardiovascular) system RC666-701 |
spellingShingle |
human induced pluripotent stem cell endothelial cell smooth muscle cell stem cell cardiovascular disease regenerative medicine Diseases of the circulatory (Cardiovascular) system RC666-701 Jee Eun Oh Cholomi Jung Young-sup Yoon Human Induced Pluripotent Stem Cell-Derived Vascular Cells: Recent Progress and Future Directions |
description |
Human induced pluripotent stem cells (hiPSCs) hold great promise for cardiovascular regeneration following ischemic injury. Considerable effort has been made toward the development and optimization of methods to differentiate hiPSCs into vascular cells, such as endothelial and smooth muscle cells (ECs and SMCs). In particular, hiPSC-derived ECs have shown robust potential for promoting neovascularization in animal models of cardiovascular diseases, potentially achieving significant and sustained therapeutic benefits. However, the use of hiPSC-derived SMCs that possess high therapeutic relevance is a relatively new area of investigation, still in the earlier investigational stages. In this review, we first discuss different methodologies to derive vascular cells from hiPSCs with a particular emphasis on the role of key developmental signals. Furthermore, we propose a standardized framework for assessing and defining the EC and SMC identity that might be suitable for inducing tissue repair and regeneration. We then highlight the regenerative effects of hiPSC-derived vascular cells on animal models of myocardial infarction and hindlimb ischemia. Finally, we address several obstacles that need to be overcome to fully implement the use of hiPSC-derived vascular cells for clinical application. |
format |
article |
author |
Jee Eun Oh Cholomi Jung Young-sup Yoon |
author_facet |
Jee Eun Oh Cholomi Jung Young-sup Yoon |
author_sort |
Jee Eun Oh |
title |
Human Induced Pluripotent Stem Cell-Derived Vascular Cells: Recent Progress and Future Directions |
title_short |
Human Induced Pluripotent Stem Cell-Derived Vascular Cells: Recent Progress and Future Directions |
title_full |
Human Induced Pluripotent Stem Cell-Derived Vascular Cells: Recent Progress and Future Directions |
title_fullStr |
Human Induced Pluripotent Stem Cell-Derived Vascular Cells: Recent Progress and Future Directions |
title_full_unstemmed |
Human Induced Pluripotent Stem Cell-Derived Vascular Cells: Recent Progress and Future Directions |
title_sort |
human induced pluripotent stem cell-derived vascular cells: recent progress and future directions |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/09ffb386a6834076a432c3504635c24b |
work_keys_str_mv |
AT jeeeunoh humaninducedpluripotentstemcellderivedvascularcellsrecentprogressandfuturedirections AT cholomijung humaninducedpluripotentstemcellderivedvascularcellsrecentprogressandfuturedirections AT youngsupyoon humaninducedpluripotentstemcellderivedvascularcellsrecentprogressandfuturedirections |
_version_ |
1718411722998415360 |